- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04294407
Using the Movement and Electromyographical Analyses to Assess the Muscle Spasticity
Assessment of Upper Extremity Muscle Spasticity and Impedance Using the Movement and Electromyographical Analyses
Study Overview
Detailed Description
Purpose 1 : To collect upper limb muscle activity parameters of healthy adults and stroke patients to establish a database of doing hand circular motion activity.
Purpose 2 : To test the reliability of this refined muscle testing by collecting the muscle activity during hand circular motion activity.
Purpose 3 : To compare the results of the EMG signal strength with other evaluation methods such as the modified Ashworth scale and dynamometer to understand the relationship between the EMG signal and each evaluation results.
Purpose 4 : To compare the differences in electromyographic signals, muscle strength, and joint angle between healthy adults and stroke patients.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Tainan, Taiwan, 704
- Recruiting
- National Cheng-Kung University Hospital
-
Contact:
- Li-Chieh Kuo, Ph. D.
- Phone Number: 5908 886-62353535
- Email: jkkuo@mail.ncku.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 20 to 65 years old
- with the clinical diagnosis of stroke
- Mini-mental state examination (MMSE) score ≥ 25 points
Exclusion Criteria:
- pain, subluxation or related medical history of shoulder, elbow, and wrist joints within six months
- surgery on shoulder, elbow or wrist
- with muscle or nerve disorders or diseases that significantly affect the performance of the upper extremities
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Stroke group
20 to 65 years old patients, with the clinical diagnosis of stroke (Mini-mental state examination (MMSE) score of ≥25)
|
no intervention in this study
|
|
Healthy group
20 to 65 years old healthy subjects, without the clinical diagnosis of stroke
|
no intervention in this study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Surface electromyography device--Baseline
Time Frame: Baseline
|
The wireless EMG system will be used to record muscle activity of biceps brachii, triceps brachii, anterior deltoid, and brachioradialis during the hand circular motion activity.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
Baseline
|
|
Surface electromyography device--3 days after baseline
Time Frame: 3 days after baseline
|
The wireless EMG system will be used to record muscle activity of biceps brachii, triceps brachii, anterior deltoid, and brachioradialis during the hand circular motion activity.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
3 days after baseline
|
|
Surface electromyography device--6 days after baseline
Time Frame: 6 days after baseline
|
The wireless EMG system will be used to record muscle activity of biceps brachii, triceps brachii, anterior deltoid, and brachioradialis during the hand circular motion activity.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
6 days after baseline
|
|
Dynamometer device- muscle strength--Baseline
Time Frame: Baseline
|
A digital dynamometer will be used to measure the maximum elbow flexion/extension force as muscle strength.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
Baseline
|
|
Dynamometer device- range of motion--Baseline
Time Frame: Baseline
|
A digital dynamometer will be used to measure the range of motion of elbow flexion/extension.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
Baseline
|
|
Dynamometer device- muscle strength--3 days after baseline
Time Frame: 3 days after baseline
|
A digital dynamometer will be used to measure the maximum elbow flexion/extension force as muscle strength.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
3 days after baseline
|
|
Dynamometer device- range of motion--3 days after baseline
Time Frame: 3 days after baseline
|
A digital dynamometer will be used to measure the range of motion of elbow flexion/extension.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
3 days after baseline
|
|
Dynamometer device- muscle strength--6 days after baseline
Time Frame: 6 days after baseline
|
A digital dynamometer will be used to measure the maximum elbow flexion/extension force as muscle strength.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
6 days after baseline
|
|
Dynamometer device- range of motion--6 days after baseline
Time Frame: 6 days after baseline
|
A digital dynamometer will be used to measure the range of motion of elbow flexion/extension.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
6 days after baseline
|
|
Modified Ashworth Scale--Baseline
Time Frame: Baseline
|
Modified Ashworth Scale (MAS) is a useful assessment tool to classify spasticity.The testing procedure of the MAS is to passively move the joint by the examiner and to feel the resistance during the movements.
The scoring of the MAS included 6 level (0, 1, 1+, 2, 3, 4), where no increase muscle tone was score as 0 and rigid joint was score as 4.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
Baseline
|
|
Modified Ashworth Scale--3 days after baseline
Time Frame: 3 days after baseline
|
Modified Ashworth Scale (MAS) is a useful assessment tool to classify spasticity.The testing procedure of the MAS is to passively move the joint by the examiner and to feel the resistance during the movements.
The scoring of the MAS included 6 level (0, 1, 1+, 2, 3, 4), where no increase muscle tone was score as 0 and rigid joint was score as 4.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
3 days after baseline
|
|
Modified Ashworth Scale--6 days after baseline
Time Frame: 6 days after baseline
|
Modified Ashworth Scale (MAS) is a useful assessment tool to classify spasticity.The testing procedure of the MAS is to passively move the joint by the examiner and to feel the resistance during the movements.
The scoring of the MAS included 6 level (0, 1, 1+, 2, 3, 4), where no increase muscle tone was score as 0 and rigid joint was score as 4.
These data would be collected three times.
(Baseline, 3 days after baseline, 6 days after baseline)
|
6 days after baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Fugl-Meyer Upper Extremity Scale
Time Frame: Baseline
|
The Fugl-Meyer Upper Extremity Scale is an assessment scale for upper limb function of stroke patients.
The scale has 33 movements, which can be rated as 0 to 2 points, of which 0 is impossible and 1 is achievable. 2 points can be completely achieved.
FMUE scale has good reliability and validity.
|
Baseline
|
|
Box and Block Test
Time Frame: Baseline
|
The main purpose of the BBT test is to measure the function of the hand.
The test method is to calculate the number of blocks that can be moved from one side of the box across the partition to the other side with one hand in one minute.
|
Baseline
|
|
Action Research Arm Test
Time Frame: Baseline
|
ARAT is a tool used to evaluate the function of upper limbs of stroke patients.
The main test content is to reach out and grasp different objects in a standardized environment, and score the action based on the time to complete the action.
There are 19 test items, each of which is scored 4 levels (0 ~ 3).
The higher the score, the better the movement performance.
|
Baseline
|
|
Motor Activity Log
Time Frame: Baseline
|
It is mainly used to evaluate daily life functions, including the frequency of use of motion and the evaluation of motion quality.
It is a five-point questionnaire with a total of about 30 questions.
The average score of the two items of frequency of use and motion quality will be calculated separately.
|
Baseline
|
|
EQ-5D
Time Frame: Baseline
|
It is mainly used to assess the quality of life.
It is a questionnaire-type scale with a total of six questions.
Check the descriptions that match your condition (for example, I cannot perform my daily activities) and score my health status today.
0 to 100 points (100 points: best state; 0 points: worst state of health)
|
Baseline
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A-ER-107-317
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown